<DOC>
	<DOCNO>NCT02291926</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy human umbilical cord mesenchymal stem cell ( hUC-MSC ) articular cartilage defect knee .</brief_summary>
	<brief_title>Human Umbilical Cord Mesenchymal Stem Cell Transplantation Articular Cartilage Defect</brief_title>
	<detailed_description>Human articular cartilage limit repair potential.Cell-based strategy explore chondrocytes mesenchymal stem cell ( MSCs ) extensive basic science preclinical studies.However concept autologous chondrocyte implantation ideal , focus cartilage repair shift toward mesenchymal stem cell . To investigate effect hUC-MSC treatment articular cartilage defect , 20 patient enrol receive 4 time hUC-MSC transplantation .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Patients must consent write participate study sign date informed consent document Healthy patient major history illness Patients must diagnosis osteoarthritis radiographic criterion Kellgren Lawrence grade 24 Patients needs invasive intervention arthroplasty due response exist pain medication Patients must Grade 4 ( 0~10 point numeric scale ) pain least four month Patient 's damage cartilage area range 26cm2 Pregnant woman lactate mother Patients receive antiinflammatory drug include herbdrug within 14 day Patients received drug intraarticular injection treatment within 2 month prior enrollment Patients positive human immunodeficiency ( HIV ) screen indicative current pas infection Impaired liver function , abnormal blood coagulation , combine tumor special condition Patients participate clinical trial within three month prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Human Umbilical Cord Mesenchymal Stem Cell</keyword>
	<keyword>Mesenchymal Stem Cell</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>